DiagnosticsOphthalmic diagnoses in the ED: optic neuritis
Introduction
In the United States, the annual incidence of optic neuritis in a predominately white community is approximately 5 per 100,000 per year, whereas the prevalence is 115 per 100,000 [1]. Most cases occur in patients between 15 and 45 years old, with women affected more frequently than men.
Most cases are due to inflammatory demyelination of the optic nerve. The pathophysiology leading to the demyelination is most often idiopathic. Occasionally, optic neuritis may be due to an infectious process involving the orbits or paranasal sinuses. Optic neuritis caused by inflammatory demyelination carries a strong association with multiple sclerosis (MS), but cases may occur in isolation.
The diagnosis of this disease is made based on history and physical exam findings. However, magnetic resonance imaging (MRI) may yield prognostic information in terms of the patient's future risk for development of MS. Despite a large amount of recent research regarding the therapy for optic neuritis, the treatment remains controversial.
Section snippets
Case example
A 28-year-old woman arrived at the emergency department (ED) complaining of a 3-day history of progressive headache, eye pain, and unilateral blurred vision. She denied a history of chronic headache and stated that she had previously been in good health. There is no history of recent trauma.
On physical examination, the patient was alert and oriented. Her vital signs were normal. The visual acuity was tested at 20/20 on the right side and 20/200 on the left. Cranial nerves II through XII were
Pathophysiology and clinical manifestations
Optic neuritis represents an inflammatory and demyelinating condition of the optic nerve. The most common form arises from idiopathic demyelination of the nerve. This degeneration of the optic nerve represents the most common cause of optic nerve disease. Pathologically, the nerve is surrounded by inflammatory cells initiating swelling and fragmentation of the nerve tissue. Further degeneration occurs as macrophages phagocytize myelin breakdown products [2]. The other, less common causes of
Diagnosis
Optic neuritis is generally a clinical diagnosis based on history and physical examination. In cases with typical clinical symptoms, laboratory testing is unlikely to be revealing [7], [8]. Symptoms often include a reduced visual acuity and color perception, ocular pain, and APD in the affected eye [9], [10], [11], [12]. The first 2 symptoms can be tested by using a standard eye chart and pseudoisochromatic plates.
Most cases of optic neuritis are retrobulbar and the fundoscopic examination will
Treatment
There is no known cure for optic neuritis. Much of the current understanding of the treatment comes from the Optic Neuritis Treatment Trial (ONTT), which was a multicenter trial composed of 457 patients with optic neuritis. The primary objective of this study was to assess the benefit of corticosteroid treatment of optic neuritis. Numerous follow-up studies were performed to investigate the potential benefit of steroids for treatment of optic neuritis and prevention of MS.
In the ONTT, patients
Key points
- •
Optic neuritis is a clinical diagnosis that often includes eye pain, a relatively abrupt vision and color differentiation loss, and an afferent papillary defect.
- •
Intravenous steroids have been shown to speed the recovery of vision without affecting the final visual outcome.
- •
Steroids may also decrease the symptom onset of MS over the first 2 to 3 years after optic neuritis.
- •
Brain MRI is the most useful predictor of subsequent development of MS.
References (28)
- et al.
Optic neuritis
Ann Emerg Med
(1984) - et al.
Relative afferent papillary defects on optic neuritis
Am J Ophthalmol
(1981) - et al.
Management of acute optic neuritis
Lancet
(2002) - et al.
Enhancement and demyelination of the intraorbital optic nerve: fat suppression magnetic resonance imaging
Ophthalmology
(1992) - et al.
Use of magnetic resonance imaging to differentiate optic neuritis and nonarteritic anterior ischemic optic neuropathy
Ophthalmology
(2002) - et al.
The impact of the optic neuritis treatment trial on the practices of ophthalmologists and neurologists
Ophthalmology
(1999) - et al.
Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomized study
Lancet
(2001) - et al.
Optic neuritis: a population-based study in Olmsted County, Minnesota
Neurology
(1995) Visual function more than 10 years after optic neuritis: experience of the Optic Neuritis Treatment Trial
Am J Ophthalmol
(2004)- et al.
The pathophysiology of acute optic neuritis: an association of gadolinium leakage with clinical and electrophysiological deficits
Brain
(1991)